738 related articles for article (PubMed ID: 17854045)
21. Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients.
van Velzen M; Missotten T; van Loenen FB; Meesters RJ; Luider TM; Baarsma GS; Osterhaus AD; Verjans GM
J Clin Virol; 2013 Jul; 57(3):215-21. PubMed ID: 23582986
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.
Gaudreau A; Hill E; Balfour HH; Erice A; Boivin G
J Infect Dis; 1998 Aug; 178(2):297-303. PubMed ID: 9697707
[TBL] [Abstract][Full Text] [Related]
23. Antiherpetic properties of acyclovir 5'-hydrogenphosphonate and the mutation analysis of herpes virus resistant strains.
Gus'kova AA; Skoblov MY; Korovina AN; Yasko MV; Karpenko IL; Kukhanova MK; Andronova VL; Galegov GA; Skoblov YS
Chem Biol Drug Des; 2009 Oct; 74(4):382-9. PubMed ID: 19691467
[TBL] [Abstract][Full Text] [Related]
24. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
Chibo D; Mijch A; Doherty R; Birch C
J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
[TBL] [Abstract][Full Text] [Related]
25. Subclinical generation of acyclovir-resistant herpes simplex virus with mutation of homopolymeric guanosine strings during acyclovir therapy.
Daikoku T; Tannai H; Honda M; Onoe T; Matsuo K; Onoye Y; Nishizawa M; Kawana T; Okuda T; Hasegawa T; Shiraki K
J Dermatol Sci; 2016 Jun; 82(3):160-5. PubMed ID: 26917345
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of ASP2151, a helicase-primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivo.
Himaki T; Masui Y; Chono K; Daikoku T; Takemoto M; Haixia B; Okuda T; Suzuki H; Shiraki K
Antiviral Res; 2012 Feb; 93(2):301-304. PubMed ID: 22155691
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Schmit I; Boivin G
J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
[TBL] [Abstract][Full Text] [Related]
28. Acyclovir sensitivity of sequential herpes simplex virus type 2 isolates from the genital mucosa of immunocompetent women.
Gupta R; Hill EL; McClernon D; Davis G; Selke S; Corey L; Wald A
J Infect Dis; 2005 Sep; 192(6):1102-7. PubMed ID: 16107966
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic and genotypic acyclovir resistance surveillance of genital herpes simplex virus 2 in South Africa.
Muller EE; Maseko DV; Kularatne RS
Antiviral Res; 2022 Apr; 200():105277. PubMed ID: 35271913
[TBL] [Abstract][Full Text] [Related]
30. Sequential switching of DNA polymerase and thymidine kinase-mediated HSV-1 drug resistance in an immunocompromised child.
Stránská R; van Loon AM; Bredius RG; Polman M; Nienhuis E; Beersma MF; Lankester AC; Schuurman R
Antivir Ther; 2004 Feb; 9(1):97-104. PubMed ID: 15040541
[TBL] [Abstract][Full Text] [Related]
31. Screening of herpes simplex virus type 1 isolates for acyclovir resistance using DiviTum® assay.
Sauerbrei A; Vödisch S; Bohn K; Schacke M; Gronowitz S
J Virol Methods; 2013 Mar; 188(1-2):70-2. PubMed ID: 23246510
[TBL] [Abstract][Full Text] [Related]
32. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
[TBL] [Abstract][Full Text] [Related]
33. Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.
Burrel S; Bonnafous P; Hubacek P; Agut H; Boutolleau D
Antiviral Res; 2012 Dec; 96(3):386-90. PubMed ID: 23041200
[TBL] [Abstract][Full Text] [Related]
34. Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses.
Frobert E; Cortay JC; Ooka T; Najioullah F; Thouvenot D; Lina B; Morfin F
Antiviral Res; 2008 Jul; 79(1):28-36. PubMed ID: 18336925
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
[TBL] [Abstract][Full Text] [Related]
36. Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues.
Bestman-Smith J; Schmit I; Papadopoulou B; Boivin G
J Virol; 2001 Apr; 75(7):3105-10. PubMed ID: 11238837
[TBL] [Abstract][Full Text] [Related]
37. Assessment trials of the therapeutic efficacy of the drug "Zovirax" in some recurrent ocular and genital herpetic infections.
Muţiu A; Sahnazarov N; Crişan I
Rom J Virol; 1998; 49(1-4):27-42. PubMed ID: 10892424
[TBL] [Abstract][Full Text] [Related]
38. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
[TBL] [Abstract][Full Text] [Related]
39. Recurrent herpes simplex virus hepatitis after liver retransplantation despite acyclovir therapy.
Longerich T; Eisenbach C; Penzel R; Kremer T; Flechtenmacher C; Helmke B; Encke J; Kraus T; Schirmacher P
Liver Transpl; 2005 Oct; 11(10):1289-94. PubMed ID: 16184558
[TBL] [Abstract][Full Text] [Related]
40. Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients.
Morfin F; Souillet G; Bilger K; Ooka T; Aymard M; Thouvenot D
J Infect Dis; 2000 Jul; 182(1):290-3. PubMed ID: 10882609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]